Status:

RECRUITING

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

Lead Sponsor:

University of Florida

Conditions:

Alpha-1 Antitrypsin Deficiency

AAT Deficiency

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their ability to work.

Detailed Description

AAT deficiency is a genetic disorder that affects around 100,000 people in the USA, including 1-3% of all people diagnosed with chronic obstructive pulmonary disease (COPD). In AAT deficient people di...

Eligibility Criteria

Inclusion

  • Signed informed consent
  • Male or female 18 years of age or older
  • Negative pregnancy test for women of childbearing potential
  • Hemoglobin \>12.5 g/dl measured on the day of participation
  • Negative urine nicotine test

Exclusion

  • Pregnancy or breastfeeding
  • Weight \< 50 kg
  • History of anemia requiring blood transfusions, erythropoietin supplementation, or iron supplementation within the past 36 months
  • Known hemoglobin \<12.5 g/dl within the past 90 days
  • Systolic blood pressure \> 180 mmHg and/or diastolic blood pressure \>100 mmHg
  • Poor venous access
  • Large volume blood donation (\>200 ml or 7 ounces) within the previous 56 days (e.g. blood donation for the purposes of blood banking)
  • Clinically significant cardiac, hemostatic or neurological impairment or any other significant medical condition that, in the opinion of the investigator would affect subject safety (e.g., recent myocardial infarction, history of prolonged bleeding time, cerebral vascular accident, advanced cancer or uncontrolled medical condition)
  • Psychiatric or cognitive disturbance or illness that would affect subject safety
  • Current smoker

Key Trial Info

Start Date :

August 9 2007

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 20 2033

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT01851642

Start Date

August 9 2007

End Date

July 20 2033

Last Update

November 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shands at the University of Florida

Gainesville, Florida, United States, 32610

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs | DecenTrialz